“In 2006, in the midst of a growing opioid epidemic, the FDA approved the new narcotic painkiller Opana.
Under the name Numorphan, it had been abused in the 1960s and 1970s until it was removed from the market. When injected, the drug is 10 times as potent as morphine.
And now there is a familiar problem.
Known generically as oxymorphone, the FDA approved the new version of the drug — made by Endo Pharmaceuticals — in 2006 as both an immediate-release and extended-release pill. Then in December 2011, the agency approved a new abuse-deterrent version — but users have been able to foil the anti-injection mechanism and have been shooting up Opana.
In addition to overdose risk, abuse of Opana by injection has been tied to a recent outbreak of HIV in rural Indiana as well as a surge in hepatitis C infections in several Appalachian states.”
Read more at: http://www.medpagetoday.com/Psychiatry/Addictions/51448
Source: MedPageToday.com – May 1o, 2015